Skip to main content

NCI Funding Notices for COVID-19

NCI is providing funding for research on COVID-19 and revising certain existing grants and cooperative agreements to make funds available to help address the public health crisis. New funding notices will be added to this page as they become available.

Notice Number Title Release Date Expiration Date
NOT-CA-20-066 Notice of Intent to Publish a Funding Opportunity Announcement for Serological Sciences Centers of Excellence 05/15/2020  
NOT-CA-20-065 Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences 05/14/2020 05/26/2020
NOT-CA-20-054 Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis 04/28/2020  
NOT-CA-20-042 National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) 04/10/2020 06/26/2020
NOT-CA-20-043 National Cancer Institute Announcement Regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) 04/09/2020 06/26/2020
NOT-CA-20-048 Notice of National Cancer Institute (NCI) Participation in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" 04/03/2020 01/25/2022
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “NCI Funding Notices for COVID-19 was originally published by the National Cancer Institute.”